The Ethics of the U.S. Antidumping Laws and Policies

2016 ◽  
Author(s):  
Robert W. McGee
Keyword(s):  
Laws And Policies ◽  
Antidumping Laws ◽  
The U.S

Gun Ownership and Gun Purchasing

2020 ◽  
pp. 339-356
Author(s):  
Lacey Nicole Wallace
Keyword(s):  
Real Life ◽  
The State ◽  
Gun Ownership ◽  
Mass Shootings ◽  
Federal Level ◽  
Laws And Policies ◽  
The U.S ◽  
Ownership Patterns

Much of the debate over mass shootings has centered on the broader topics of gun ownership and gun purchase. This chapter details what is currently known and unknown about gun ownership in the U.S., including why individuals choose to own guns and the demographics of gun owners. While the focus is on adults, this chapter also touches on the reasons juveniles may opt to carry or possess guns. This chapter further addresses mass shootings by examining how mass shootings affect gun purchase and gun ownership patterns when they occur. The sources and types of guns used in mass shootings are also discussed. Lastly, the chapter highlights several efforts to restrict gun purchasing, all aimed at reducing the number of mass shootings that occur in the U.S. Throughout the chapter, specific, real-life examples are used to provide context for discussion. Examples of laws and policies at the state and federal level are provided as additional context.

scholarly journals Antidumping Charges Against China: A Comprehensive Analysis Of Proponents, Opponents, And Its Impact On U.S. Companies

2011 ◽  
Vol 3 (6) ◽  
Author(s):  
Ki Hee Kim ◽  
Cho Kin Leung ◽  
Vincent J Vicari
Keyword(s):  
Direct Investment ◽  
High Technology ◽  
Comprehensive Analysis ◽  
Trade Surplus ◽  
Foreign Companies ◽  
Pros And Cons ◽  
Foreign Governments ◽  
Antidumping Laws ◽  
Foreign Competitors ◽  
The U.S

Few nations have changed as fastor as Dramaticallyas China has since the 1970s. The worlds most populous nation has radically liberalized its economy and gone from producing low-quality and simple export to sophisticated high- technology goods, while nurturing a vibrant private sector and attracting nearly $500 billion in foreign direct investment (FDI). Chinas total exports grew eightfoldto over $380 billionbetween 1990 and 2003. Chinas share of global exports will reach 6 percent in 2003, compared to 3.9 percent in 2000. The U.S. has lost about 2.6 million manufacturing jobs since 2001. While private economists say that most of he job losses reflected improved productivity at U.S. factories, many in Congress and within industry say China blame China. Chinas soaring economy has turned it into manufacturing juggernaut that maintains the largest trade surplus of many nations, including the U.S. U.S. law provides for the protection of American manufacturers form unfair foreign trade practices. If U.S. companies believe that foreign competitors are dumping merchandise in the U.S. or are being subsidized by foreign governments, they may file for relief with the U.S. Department of Commerces International Trade Administration and the U.S. Trade Commission. Antidumping levies duties on goods dumped on the U.S. market. One of the most contested issues is whether U.S. trade laws, in particular the antidumping laws, should be open to negotiation. It should for the benefits of U.S. customers and U.S. businesses. This research will focus on dumping charges against China and evaluate pros and cons of U.S. antidumping laws against foreign companies and its impact on U.S. consumers and businesses.

scholarly journals How to prevent the next Marathon Pharmaceuticals

F1000Research ◽  
2018 ◽  
Vol 7 ◽  
pp. 74
Author(s):  
Frank S. David ◽  
Richa Dixit
Keyword(s):  
Drug Price ◽  
Federal Agencies ◽  
State Governments ◽  
Regulatory Policies ◽  
Price Increases ◽  
Drug Companies ◽  
Fda Approval ◽  
The Future ◽  
Laws And Policies ◽  
The U.S

In recent years, several drug companies have exploited U.S. regulatory policies to acquire exclusive rights to cheap therapies and substantially raise their prices, and Federal agencies and state governments are exploring various ways to prevent or punish such behavior in the future. Among these cases, however, Marathon Pharmaceuticals’ handling of Emflaza (deflazacort) is unique, because the drug was previously only available abroad, and was never previously sold in the U.S. before the company obtained FDA approval for it. Thus, laws and policies designed to address price hikes on already-marketed drugs are unlikely to prevent additional Marathon-like scenarios. In this article, we describe in more detail the unique features of Emflaza compared with these other recent cases of drug price increases, determine the likelihood that similar situations will arise in the future, and explore legislative and administrative options to specifically prevent such behavior.

Sign in / Sign up

Export Citation Format

Share Document